Director Adler Oz details RSU and warrant holdings in Nexera (NEXR)
Rhea-AI Filing Summary
Nexera Technologies Ltd director Adler Oz filed an amended statement of beneficial ownership that lists his existing equity awards rather than new trades. As of March 18, 2026, he holds 2 ordinary shares and a mix of restricted share units that vest over time.
The filing notes 1,448 RSUs granted on September 16, 2025, which vest in equal quarterly installments of 12.5% beginning December 10, 2025; 362 of these RSUs had vested and 1,086 remained unvested as of that date. It also discloses 8,100 additional RSUs granted on January 1, 2026, vesting quarterly at 12.5% starting January 1, 2026, all unvested as of March 18, 2026, plus ordinary warrants exercisable for 2 ordinary shares at a fixed price through August 30, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Adler Oz
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary warrants | -- | -- | -- |
| holding | Warrants to purchase ordinary shares | -- | -- | -- |
Holdings After Transaction:
Ordinary warrants — 2 shares (Direct);
Warrants to purchase ordinary shares — 1,450 shares (Direct)
Footnotes (1)
- F1. Represents (i) 2 ordinary shares, (ii) 1,448 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 362 RSUs have vested and 1,086 remain unvested as of March 18, 2026; and (ii) 8,100 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026.
Key Figures
Ordinary shares held: 2 shares
First RSU grant: 1,448 RSUs
Vested RSUs from first grant: 362 RSUs
+5 more
8 metrics
Ordinary shares held
2 shares
Direct holdings as described in footnote as of March 18, 2026
First RSU grant
1,448 RSUs
Granted September 16, 2025, vesting quarterly at 12.5% from December 10, 2025
Vested RSUs from first grant
362 RSUs
Portion vested under 1,448-unit grant as of March 18, 2026
Unvested RSUs from first grant
1,086 RSUs
Remaining under 1,448-unit grant as of March 18, 2026
Second RSU grant
8,100 RSUs
Granted January 1, 2026, vesting quarterly at 12.5% from January 1, 2026
Unvested RSUs second grant
8,100 RSUs
All remained unvested as of March 18, 2026
Ordinary warrants exercise price
43,749.20 per share
Exercise price for warrants into 2 ordinary shares, expiring August 30, 2027
Underlying shares from warrants
2 shares
Ordinary shares underlying ordinary warrants held directly
Key Terms
restricted share units ("RSUs"), vesting commencement date, ordinary warrants, beneficial ownership
4 terms
vesting commencement date financial
"RSUs Granted on September 16, 2025 and the vesting commencement date is September 10, 2025"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
ordinary warrants financial
""Ordinary warrants" with underlying security title "Ordinary shares" and an expiration date"
A warrant that gives its holder the right to buy ordinary shares (common stock) at a fixed price for a set period. Think of it as a coupon that lets an investor purchase a share later at a predetermined price; if the market price rises above that price the coupon is valuable, otherwise it may expire worthless. Investors care because exercising warrants can amplify gains but also dilute existing shareholders by increasing the number of shares outstanding.
beneficial ownership financial
"filed an amended statement of beneficial ownership that lists his existing equity awards"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What does Nexera Technologies (NEXR) director Adler Oz report in this Form 3/A?
Adler Oz reports existing holdings in Nexera Technologies, including 2 ordinary shares, multiple restricted share unit grants, and ordinary warrants. The filing updates his beneficial ownership position rather than recording new share purchases or sales.
What is the vesting schedule for Adler Oz’s 1,448 RSUs in NEXR?
The 1,448 RSUs granted on September 16, 2025 vest in equal quarterly installments of 12.5% beginning on December 10, 2025. By March 18, 2026, 362 RSUs had vested and 1,086 remained unvested under this grant.
What are the details of Adler Oz’s 8,100 RSUs in Nexera Technologies (NEXR)?
The 8,100 RSUs were granted on January 1, 2026 and vest in equal quarterly installments of 12.5% starting on January 1, 2026. All 8,100 RSUs remained unvested as of March 18, 2026, according to the filing footnote.
What ordinary warrant position does Adler Oz report in Nexera Technologies (NEXR)?
Adler Oz reports ordinary warrants exercisable into 2 ordinary shares of Nexera Technologies at an exercise price of 43,749.20 per share, with an expiration date of August 30, 2027. These warrants are held directly under his name.
AI-generated analysis. How Rhea-AI works. Not financial advice.
